NCT05486455 Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers
| NCT ID | NCT05486455 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital St. Joseph, Marseille, France |
| Condition | Smoking |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2022-11-04 |
| Primary Completion | 2028-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2022-11-04 with a primary completion date of 2028-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Diagnostic performance of low-dose chest CT scan combined with lung-RADS classification (version 1.1) for lung cancer screening among former and current smokers.
Eligibility Criteria
Inclusion Criteria: * Male or female 50-80 years old * Active smoker (≥ 15 PA) or former smoker (≥ 15 PA) Exclusion Criteria: * Recent history of chest CT scan (within 12 months) * Person unable to climb 2 floors * Weight \> 140kg * Personal history of cancer \< 5 years (currently being monitored by thoracic imaging)
Contact & Investigator
Arnaud Boyer, MD
PRINCIPAL INVESTIGATOR
Hopital Saint Joseph Marseille
Frequently Asked Questions
Who can join the NCT05486455 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 80 Years, studying Smoking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05486455 currently recruiting?
Yes, NCT05486455 is actively recruiting participants. Contact the research team at cbielman@hopital-saint-joseph.fr for enrollment information.
Where is the NCT05486455 trial being conducted?
This trial is being conducted at Marseille, France.
Who is sponsoring the NCT05486455 clinical trial?
NCT05486455 is sponsored by Hospital St. Joseph, Marseille, France. The principal investigator is Arnaud Boyer, MD at Hopital Saint Joseph Marseille. The trial plans to enroll 1,000 participants.